They have not been selling. Prospectus states: "We may not sell any securities under this prospectus without delivery of the applicable prospectus supplement. "
none sold. and wont be until way higher. Minimal dilution.
WOuld be nice to see some insider buying. would really show some confidence
NVIV too - spinal chord injury repair. They have their first patient with product to help spinal chord injury
The company knows that positive news is on the way with large dollar contracts. More than just ebola, vaccines for everything will license IBiolaunch. Company is set to sell $100 million in stock at much higher prices with minimal dilution. Smart for them to do this NOW instead of spooking the imminent run. The money will only increase shareholder value by allowing them to expand and do drug trials for multi-billion dollar drugs.
Here are my favorite stocks:
IBIO - vaccine production and pipeline
BLRX - incredible pipeline and most unbelievably underpriced stock in history - just needs (AND WILL) to be discovered
DARA- great products - massively underpriced
CANF - great potential and late stage pipeline. Also incredibly underpriced - I do see a secondary coming with this one
Others- non biotech
TSL - best solar play
SIMO - best chip play with divi
TICC, PSEC - business development companies - great divis
Also, BLRX is a TEVA spinoff. CANF and BLRX are those types of stocks that people wonder why they were so low. 3-5 years from now these will both be 10 to even 100x baggers
This filing definitely shows that they are expecting a much higher price. $100 million dollars. notice they did not mention the number of shares like most filings. They are expecting to sell into a large news story is my guess. They are prepping themselves for vaccine BARDA contract news, which will send the stock over 10.
Dilution will be minimal above 10. They certainly are not going to dilute the stock at the current price especially given enough cash on hand through end of next year with revenue coming in from GE plant and others
They have a series of great candidates in various stages including for stem cell mobilization, oncology, celiac disease, infections, heart issues etc. go to Bioline website.
BLRX and CANF - extremely underpriced multiple candidates
IBIO - novel state of the art vaccine play with ebola contract coming soon
NVIV - Spinal chord cure - first patient having encouraging results - making news headlines
Furthermore, BLRX has a much better cash position, partners and low cash burn rate. no need for secondary
I have a law firm more interested in high profile advocacy than making any more money (at least short term). About time this kind of market manipulation stops. there needs to be consequences for lies and slander to make millions by lies
Great people. I just need a list of names and e-mail addresses. Please send to montanafreeride9 at yahoo
Zmapp specifically mentioned. Zmapp will be produced through Caliber = IBIO
I am quite serious about pursuing this. A precedent can be set here. And no, it is not ok and lawfirms to go after slander. Need the attention of a motivated attorney or DA and pressure the sec as much as possible. please join me. One can not steal 150 million in market cap and get away with it. They put people in jail for stealing 50 dollars of items from the convenience store but not for stealing 150 million? about time for this to stop
Lets get a list together for a firm and also for the SEC. Lets do some investigations into their financials Anyone know approximate cash value. An investigation will lead to manipulator hedge funds Are they part of a publicly traded company?
koze at yhoo
They have multiple potential billion dollar drugs. If they had a billion dollar drug already approved then the market cap would be 20-100X what it is now. Thats why we are invested here. the potential is unreal. And they have multiple shots to get there. DOnt forget this is a Teva spinoff
I agree. The technology is just about to go mainstream. People dont realize how many avenues for revenue and its all royalty revenue.
Off topic: BLRX is my single favorite biotech play. Their pipeline is worth billions with only a 50 million market cap
Explain to us why this is so important. Seriously. Management does such a poor job explaining how their technology is going to change the world. Unbelievably poor job. I know enough to be invested, but please explain why this latest press release is so important.